Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;27(10):768-775.
doi: 10.1111/tbj.14276. Epub 2021 Aug 27.

A nonrandom association of breast implants and the formation of desmoid tumors

Affiliations

A nonrandom association of breast implants and the formation of desmoid tumors

Philippos Apolinario Costa et al. Breast J. 2021 Oct.

Abstract

Background: Studies suggest that surgical breast augmentation with implants is a risk factor for breast desmoid tumors. The statistical strength of this correlation is unknown, as evidence is limited to anecdotal reports.

Methods: Patients with breast desmoid tumors and a history of breast implants seen at a single center between 2000 and 2021 were identified via radiology, breast, and sarcoma databases. The standardized incidence ratio (SIR) was calculated to assess the correlation between breast desmoid tumors and breast implants. The cases were pooled with published cases for analyses. Progression-free survival curves and hazard ratios were estimated using the Kaplan-Meier method and Cox proportional-hazards modeling.

Results: Fourteen patients from one institution and 66 cases in the literature were identified. All patients were female, and the mean age was 38 years old (range 20-66). 63 patients (82%) underwent resection, 9 (12%) received chemotherapy, 3 (4%) received sorafenib, 11 (14%) received hormonal therapy, and 3 (4%) underwent active surveillance. After resection, the 2-year recurrence-free survival rate was 77% (95% CI 65%-89%). The recurrence risk was lower for resection with no residual tumor (R0) compared to microscopic (R1) or macroscopic (R2) residual tumor (HR: 0.15; 95% CI 0.02-0.8; p < 0.05). The SIR was 482 (95% CI 259-775) to 823 (95% CI 442-1322), suggesting a 482-823 times higher risk of developing a breast desmoid tumor after breast augmentation than the general population.

Conclusion: We present a nonrandom association between breast implants and desmoid tumors. Whether the tumors arise from the surgical trauma or the implant's biomaterial is unknown. When surgery is indicated, negative margins reduce the risk of recurrence.

Keywords: aggressive fibromatosis; breast desmoid tumor; breast fibromatosis; breast implant; desmoid tumor.

PubMed Disclaimer

References

REFERENCES

    1. Jeong WS, Oh TS, Sim HB, Eom JS. Desmoid tumor following augmentation mammoplasty with silicone implants. Arch Plast Surg. 2013;40(4):470-472. https://doi.org/10.5999/aps.2013.40.4.470
    1. Reitamo JJ, Häyry P, Nykyri E, Saxen E. The desmoid tumor. I.: incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol. 1982;77(6):665-673. https://doi.org/10.1093/ajcp/77.6.665
    1. Plaza MJ, Yepes M. Breast fibromatosis response to tamoxifen: dynamic MRI findings and review of the current treatment options. J Radiol Case Rep. 2012;6(3):16-23. https://doi.org/10.3941/jrcr.v6i3.897
    1. Tzur R, Silberstein E, Krieger Y, Shoham Y, Rafaeli Y, Bogdanov-Berezovsky A. Desmoid tumor and silicone breast implant surgery: is there really a connection? A literature review. Aesthetic Plast Surg. 2018;42(1):59-63. https://doi.org/10.1007/s00266-017-0948-2
    1. Vandenbroucke JP. A shortcut method for calculating the 95 per cent confidence interval of the standardized mortality ratio. Am J Epidemiol. 1982;115(2):303-304.

LinkOut - more resources